Manufactured Doubt 12/9/26
In 2023, a large international group of scientists and experts published a peer-reviewed paper in Environmental Science & Technology titled:
“Conflicts of Interest in the Assessment of Chemicals, Waste, and Pollution.”
Two of its co-authors immediately caught my attention:
Professor Bethanie Carney Almroth and Dr Marcos A. Orellana, the United Nations Special Rapporteur on toxics and human rights.
The paper is open access here:
American Chemical Society:
DOI:
Published online on 9 November 2023, the paper examines conflicts of interest in the assessment and regulation of chemicals, waste and pollution.
Section 3: “Tactics for Manufacturing Doubt”
Yes.
That is the actual heading in a peer-reviewed scientific paper:
“Tactics for Manufacturing Doubt.”
The authors explain in the abstract that part of their purpose is to:
“summarize established tactics to manufacture doubt in favor of vested interests”
They explain what they mean by this:
“to counter scientific evidence and/or to promote misleading narratives favorable to financial interests”
That distinction is incredibly important.
Manufacturing doubt does not necessarily require proving that something is harmless.
Creating enough uncertainty can itself affect what governments, regulators and the public are prepared to do.
What do these tactics look like?
The authors draw upon previous research identifying more than two dozen strategies used by organisations to counter scientific evidence or promote narratives favourable to particular industries.
One of the tactics identified in the paper is:
“To criticize study design to highlight shortcomings”
including issues such as statistical confounding or sample size, and then to overemphasise the effect those limitations have on the results.
Think about what that means.
A study doesn’t necessarily have to be disproved.
Its weaknesses can instead be magnified until uncertainty becomes the story.
The paper goes further
The authors aren’t talking only about individual scientists having different opinions.
They specifically examine conflicts of interest.
They explain that conflicts can arise from direct or indirect economic gain and warn that they can impair scientific and regulatory processes.
Then comes this extraordinary passage:
“such organizations have repeatedly sought to influence regulatory decision making and policy development”
The authors say this has occurred particularly through:
“manufacturing doubt about clear evidence documenting harm”
and identify the purpose as protecting financial interests.
Those words deserve to be read carefully.
Tobacco is one of their examples
The paper examines the tobacco industry’s historical response to scientific evidence concerning smoking and passive smoking.
The authors describe decades in which the industry systematically generated controversy concerning the health risks of tobacco.
They discuss tactics including:
“the systematic distortion of scientific evidence”
including funding scientific reports disputing evidence of harm.
The paper also describes research examining 100 articles concerning passive smoking.
Around one-third concluded that passive smoking was not harmful.
But when researchers examined authorship, 74% of the authors of those papers were affiliated with the tobacco industry.
On 17 August 2006, U.S. District Judge Gladys Kessler ruled in United States v. Philip Morris USA that major tobacco companies had violated the Racketeer Influenced and Corrupt Organizations Act (RICO), finding that they had participated in an illegal racketeering enterprise and had, for decades, lied, suppressed research and distorted scientific evidence about the health effects of smoking for financial gain.
U.S. Department of Justice — case and judgment:
That is exactly why conflicts of interest matter.
Scientific literature can look like disagreement.
But understanding who funded, produced or influenced that science can completely change how that disagreement should be interpreted.
Why was this paper written?
This is another important part of the story.
The paper was written while countries were developing a new international science-policy panel dealing with chemicals, waste and pollution.
The authors were concerned about how that body could be protected from conflicts of interest and industry influence.
Their short abstract is remarkably direct:
“The intergovernmental science−policy panel on chemicals, waste, and pollution prevention should establish clear and verifiable conflict of interest rules”
The reason?
To protect its work from industry lobbying.
The authors ultimately recommend clear conflict-of-interest rules, independent scrutiny, regular auditing and greater transparency.
They argue for a system in which chemical hazards are assessed rigorously and proactively rather than simply presumed innocent until overwhelming evidence proves otherwise.
Now look at the 84/85 Vietnam Veterans Royal Commission Map. (Below)
This is where this paper became extremely important to me.
For more than a year I have been following documents, corporations, scientists, institutions, government records and relationships connected to Agent Orange and TCDD dioxin.
I built a Map from those connections.
What the paper does it gives us a peer-reviewed framework for asking questions about those relationships.
Was scientific uncertainty simply present — or was doubt ever manufactured?
That is a question worth investigating.
Especially when the chemical involved is TCDD dioxin, the history stretches back more than half a century, and another generation is still asking what happened to them.
At the 1984–85 Agent Orange Royal Commission, Monsanto was involved in the defence, while Monsanto-paid scientist Sir Richard Doll provided scientific evidence to the Commission disputing a link between Agent Orange and cancer. He was paid to do this by Monsanto. The bank funding the litigation was Citi Bank.
Context ⬇️
A US federal court found that Philip Morris and other tobacco companies operated a decades-long coordinated scheme to deceive the public about the health risks and addictiveness of cigarettes, including manipulating science and suppressing damaging information.
👔 John S. Reed — corporate director/banker
His principal employment was banking, not tobacco or chemicals.
Career: US Army Corps of Engineers → Citibank/Citicorp (roughly 35 years) → Chairman & CEO of Citicorp from 1984 → co-chairman/co-CEO of Citigroup after the 1998 merger → retired 2000 → Chairman of the New York Stock Exchange, 2003–05.
Boards/institutions:
🚬 Philip Morris — long-serving director
☣️ Monsanto — director
🏭 United Technologies — director
🎓 MIT Corporation (Science)— member from 1980; life member from 1985; later chairman-
🔬 RAND Corporation
📊 National Bureau of Economic Research
🏥 Memorial Sloan-Kettering Cancer Center
🔬 Center for Advanced Study in the Behavioral Sciences
🔬 Russell Sage Foundation
🔬 Spencer Foundation.
Why we’re highlighting him: he provides the clean 🚬 Philip Morris ↔ ☣️ Monsanto boardroom crossover, with the Monsanto/MIT dates reaching directly into 1985.
(science, medical, money, chemicals, tobacco)
MIT → 🏭 Goodyear → 🪖 US Army Corps of Engineers (Korea) → 🎓 MIT Sloan → 🏦 Citibank. 87 years old
👨🔬 Sir Richard Doll — physician/epidemiologist
1937: qualified as a doctor at St Thomas’ Hospital Medical School.
WWII: military medical service.
1946: began research at Central Middlesex Hospital.
1950s: landmark smoking/lung-cancer epidemiology; subsequently asbestos/lung-cancer research.
1969: became Regius Professor of Medicine, Oxford University.
1979: first Warden of Green College, Oxford.
1983: retired as Warden, while remaining scientifically active.
Then his institutional/expert network:
🌍 extensively involved in development of IARC, WHO’s cancer agency
🔬 long-time chairman of the MRCLeukaemia Trials Committee
☢️ chaired Britain’s expert group on non-ionising radiation until 2002
👨🔬 major international cancer epidemiologist. (Tobacco, Asbestos, Agent Orange)
And separately:
☣️ CONSULTANCY — Monsanto
→ relationship beginning 1976
→ Doll later communicated his Agent Orange/cancer assessment to Australia’s Royal Commission.
That distinction matters: Monsanto wasn’t Doll’s employer. It was a consultancy relationship alongside his Oxford/international scientific standing.
⭐️Doll’s paid Monsanto consultancy was not disclosed to the Australian Agent Orange Royal Commission when he supplied his 1985 opinion to Justice Evatt. The relationship only became publicly known much later from Doll’s archived papers; ABC reported in 2006 that he was receiving about US$1,500 per day from Monsanto at the time.
ABC Report 2006 ⬇️
https://www.abc.net.au/listen/programs/pm/agent-orange-commission-witness-on-company-payroll/2149962
👨🔬 William R. Gaffey — Monsanto epidemiologist
This one is fundamentally different.
Gaffey was inside Monsanto.
🏭 EMPLOYER — Monsanto Company
↓
🏢 Medicine & Environmental Health
↓
👨🔬 Managing Epidemiologist — William R. Gaffey
His scientific work included Monsanto worker epidemiology, including the Nitro, West Virginia TCDD-exposed worker population.
He co-authored with Joseph Zack:
Zack & Gaffey (1983) — mortality study of workers at Monsanto’s Nitro plant.
And importantly for our architecture, documentary research into Doll’s papers identifies Gaffey as the Monsanto epidemiologist involved in managing/renewing Doll’s Monsanto consultancy.
So Gaffey is our:
INSIDE MONSANTO → OUTSIDE SCIENTIST
bridge.
🏭 Monsanto
→ 👨🔬 Gaffey
→ 👨🔬 Doll
→ ⚖️ Evatt Commission.
⚖️ Covington & Burling — LAW FIRM
This is an organisation, not a person.
Founded in Washington DC in 1919, Covington developed particularly strong expertise in federal regulation and corporate law as the US regulatory state expanded. Its own history describes its growing prominence in economic and product regulation.
The relevance to our architecture is its clientele/work:
⚖️ LAW FIRM — Covington & Burling
↙︎ 🚬 tobacco-industry representation
↘︎ 🧪 chemical-industry regulatory/legal work.
Most importantly, the contemporary 1982 Chemical Manufacturers Association minutes actually put:
R. M. Sussman — Covington & Burling
in the room with representatives of:
☣️ Monsanto
🏭 Dow Chemical
🏭 DuPont
🏭 Shell Chemical
🏭 CIBA-GEIGY
🏭 Diamond Shamrock
and other chemical manufacturers.
That’s why I’ve labelled Covington a ⚖️ LAW FIRM bridge, rather than pretending it’s a scientific institution.
🏭 Monsanto Australia Limited
→ represented before the Royal Commission by
⚖️ B. S. J. O’Keefe QC
+
⚖️ J. M. Stowe
Crucially, it then says:
“The RC Report does not indicate who were the instructing solicitors for these Counsel.”
1991: O’Keefe QC appeared for the 🚬 Tobacco Institute of Australia in Australian Federation of Consumer Organisations v Tobacco Institute of Australia.
⚖️ LAW FIRM — Clayton Utz.
Same people/institutions repeatedly crossing 🚬 tobacco → ☣️ Monsanto → 🏦 Citibank → ⚖️ legal networks.
🧪 Chemical Manufacturers Association — TRADE ASSOCIATION
Again, not a company and not a government body.
It represents the chemical industry collectively.
Its history is:
1872 — Manufacturing Chemists’ Association
↓
1978 — renamed Chemical Manufacturers Association (CMA)
↓
2000 — renamed American Chemistry Council (ACC)
↓
today — American Chemistry Council.
Its membership consisted of chemical manufacturers. Contemporary 1982 records put Monsanto, Dow, DuPont, Shell, CIBA-GEIGY and others together inside its committee structure, with ⚖️ LAW FIRM Covington & Burling present.
The association itself says its functions historically and presently include advocacy, political engagement, communications and scientific research on behalf of the chemical industry.
So this node is:
🏭 Monsanto ─┐
🏭 Dow ─────┤
🏭 DuPont ──┤
🏭 Shell ───┤
↓
🧪 CHEMICAL MANUFACTURERS ASSOCIATION
↕
⚖️ LAW FIRM — Covington & Burling
Now look at all five together
This is why the architecture caught my attention:
🚬 PHILIP MORRIS
↓ board
👔 JOHN S. REED
↓ board
☣️ MONSANTO
↓ employs
👨🔬 WILLIAM GAFFEY
↓ manages consultancy relationship
👨🔬 RICHARD DOLL
↓ scientific communication
⚖️ AUSTRALIAN AGENT ORANGE ROYAL COMMISSION
And Monsanto separately:
☣️ MONSANTO
↓ member
🧪 CHEMICAL MANUFACTURERS ASSOCIATION
↓ legal counsel/network
⚖️ LAW FIRM — COVINGTON & BURLING
↓
🚬 tobacco-industry legal work
So Reed gives us a corporate-governance bridge, while Covington/CMA gives us a professional-services/trade-association bridge, and Gaffey → Doll gives us the scientific bridge into the Australian Agent Orange evidence environment.
Read this again it’s the same architecture. ⬇️
A US federal court found that Philip Morris and other tobacco companies operated a decades-long coordinated scheme to deceive the public about the health risks and addictiveness of cigarettes, including manipulating science and suppressing damaging information.
In June 2026, the Australian Department of Veterans’ Affairs (DVA) updated its official Anzac Portal history of Agent Orange and other chemicals used in the Vietnam War, acknowledging that the Australian Government and Monsanto funded the defence of Agent Orange during the 1984–85 Royal Commission, while veterans ultimately ran out of money to continue their case.
And people wonder why I filed at The Hague
Source⬇️
Schäffer A, Groh KJ, Sigmund G, et al. (2023), “Conflicts of Interest in the Assessment of Chemicals, Waste, and Pollution,” Environmental Science & Technology, 57(48), 19066–19077.
Full open-access paper:
American Chemical Society:
DOI:
Now look at the Map below. 👇
Comments